AHCY and cancer: Metformin has recently been shown to promote global DNA methylation in non‐cancerous, cancer‐prone and metastatic cancer cells through positively modulating the activity of AHCY (the SAH hydrolase) in an AMPK‐dependent manner and promoting the accumulation of SAM.148, 149